                         SEQUENCE LISTING

<110>  University of Colorado
       The Regents of the University of Colorado, a Body Corporate
       Lyons, Traci
 
<120>  METHODS, COMPOSITIONS AND USES FOR TARGETING SEMA7A IN THE 
       DIAGNOSIS AND TREATMENT OF HEALTH CONDITIONS

<130>  106549-727482 CU5633H-PCT1

<150>  US 63/195,572
<151>  2021-06-01

<150>  US 63/234,594
<151>  2021-08-18

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  666
<212>  PRT
<213>  Homo sapiens

<220>
<223>  Human SEMA7A

<400>  1

Met Thr Pro Pro Pro Pro Gly Arg Ala Ala Pro Ser Ala Pro Arg Ala 
1               5                   10                  15      


Arg Val Pro Gly Pro Pro Ala Arg Leu Gly Leu Pro Leu Arg Leu Arg 
            20                  25                  30          


Leu Leu Leu Leu Leu Trp Ala Ala Ala Ala Ser Ala Gln Gly His Leu 
        35                  40                  45              


Arg Ser Gly Pro Arg Ile Phe Ala Val Trp Lys Gly His Val Gly Gln 
    50                  55                  60                  


Asp Arg Val Asp Phe Gly Gln Thr Glu Pro His Thr Val Leu Phe His 
65                  70                  75                  80  


Glu Pro Gly Ser Ser Ser Val Trp Val Gly Gly Arg Gly Lys Val Tyr 
                85                  90                  95      


Leu Phe Asp Phe Pro Glu Gly Lys Asn Ala Ser Val Arg Thr Val Asn 
            100                 105                 110         


Ile Gly Ser Thr Lys Gly Ser Cys Leu Asp Lys Arg Asp Cys Glu Asn 
        115                 120                 125             


Tyr Ile Thr Leu Leu Glu Arg Arg Ser Glu Gly Leu Leu Ala Cys Gly 
    130                 135                 140                 


Thr Asn Ala Arg His Pro Ser Cys Trp Asn Leu Val Asn Gly Thr Val 
145                 150                 155                 160 


Val Pro Leu Gly Glu Met Arg Gly Tyr Ala Pro Phe Ser Pro Asp Glu 
                165                 170                 175     


Asn Ser Leu Val Leu Phe Glu Gly Asp Glu Val Tyr Ser Thr Ile Arg 
            180                 185                 190         


Lys Gln Glu Tyr Asn Gly Lys Ile Pro Arg Phe Arg Arg Ile Arg Gly 
        195                 200                 205             


Glu Ser Glu Leu Tyr Thr Ser Asp Thr Val Met Gln Asn Pro Gln Phe 
    210                 215                 220                 


Ile Lys Ala Thr Ile Val His Gln Asp Gln Ala Tyr Asp Asp Lys Ile 
225                 230                 235                 240 


Tyr Tyr Phe Phe Arg Glu Asp Asn Pro Asp Lys Asn Pro Glu Ala Pro 
                245                 250                 255     


Leu Asn Val Ser Arg Val Ala Gln Leu Cys Arg Gly Asp Gln Gly Gly 
            260                 265                 270         


Glu Ser Ser Leu Ser Val Ser Lys Trp Asn Thr Phe Leu Lys Ala Met 
        275                 280                 285             


Leu Val Cys Ser Asp Ala Ala Thr Asn Lys Asn Phe Asn Arg Leu Gln 
    290                 295                 300                 


Asp Val Phe Leu Leu Pro Asp Pro Ser Gly Gln Trp Arg Asp Thr Arg 
305                 310                 315                 320 


Val Tyr Gly Val Phe Ser Asn Pro Trp Asn Tyr Ser Ala Val Cys Val 
                325                 330                 335     


Tyr Ser Leu Gly Asp Ile Asp Lys Val Phe Arg Thr Ser Ser Leu Lys 
            340                 345                 350         


Gly Tyr His Ser Ser Leu Pro Asn Pro Arg Pro Gly Lys Cys Leu Pro 
        355                 360                 365             


Asp Gln Gln Pro Ile Pro Thr Glu Thr Phe Gln Val Ala Asp Arg His 
    370                 375                 380                 


Pro Glu Val Ala Gln Arg Val Glu Pro Met Gly Pro Leu Lys Thr Pro 
385                 390                 395                 400 


Leu Phe His Ser Lys Tyr His Tyr Gln Lys Val Ala Val His Arg Met 
                405                 410                 415     


Gln Ala Ser His Gly Glu Thr Phe His Val Leu Tyr Leu Thr Thr Asp 
            420                 425                 430         


Arg Gly Thr Ile His Lys Val Val Glu Pro Gly Glu Gln Glu His Ser 
        435                 440                 445             


Phe Ala Phe Asn Ile Met Glu Ile Gln Pro Phe Arg Arg Ala Ala Ala 
    450                 455                 460                 


Ile Gln Thr Met Ser Leu Asp Ala Glu Arg Arg Lys Leu Tyr Val Ser 
465                 470                 475                 480 


Ser Gln Trp Glu Val Ser Gln Val Pro Leu Asp Leu Cys Glu Val Tyr 
                485                 490                 495     


Gly Gly Gly Cys His Gly Cys Leu Met Ser Arg Asp Pro Tyr Cys Gly 
            500                 505                 510         


Trp Asp Gln Gly Arg Cys Ile Ser Ile Tyr Ser Ser Glu Arg Ser Val 
        515                 520                 525             


Leu Gln Ser Ile Asn Pro Ala Glu Pro His Lys Glu Cys Pro Asn Pro 
    530                 535                 540                 


Lys Pro Asp Lys Ala Pro Leu Gln Lys Val Ser Leu Ala Pro Asn Ser 
545                 550                 555                 560 


Arg Tyr Tyr Leu Ser Cys Pro Met Glu Ser Arg His Ala Thr Tyr Ser 
                565                 570                 575     


Trp Arg His Lys Glu Asn Val Glu Gln Ser Cys Glu Pro Gly His Gln 
            580                 585                 590         


Ser Pro Asn Cys Ile Leu Phe Ile Glu Asn Leu Thr Ala Gln Gln Tyr 
        595                 600                 605             


Gly His Tyr Phe Cys Glu Ala Gln Glu Gly Ser Tyr Phe Arg Glu Ala 
    610                 615                 620                 


Gln His Trp Gln Leu Leu Pro Glu Asp Gly Ile Met Ala Glu His Leu 
625                 630                 635                 640 


Leu Gly His Ala Cys Ala Leu Ala Ala Ser Leu Trp Leu Gly Val Leu 
                645                 650                 655     


Pro Thr Leu Thr Leu Gly Leu Leu Val His 
            660                 665     


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct; 10mer peptide of human SEMA7A

<400>  2

Ala Asp Arg His Pro Glu Val Ala Gln Arg 
1               5                   10  


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct; 10mer peptide of human SEMA7A with linker 
       for conjugation

<400>  3

Cys Gly Gly Ala Asp Arg His Pro Glu Val Ala Gln Arg 
1               5                   10              


<210>  4
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct; 41mer peptide of human SEMA7A

<400>  4

Gln Pro Ile Pro Thr Glu Thr Phe Gln Val Ala Asp Arg His Pro Glu 
1               5                   10                  15      


Val Ala Gln Arg Val Glu Pro Met Gly Pro Leu Lys Thr Pro Leu Phe 
            20                  25                  30          


His Ser Lys Tyr His Tyr Gln Lys Val 
        35                  40      


